Crispr Therapeutics Ag (CRSP)

Net Debt

$492.41M

Quarterly · Period ending: · USD

CRSP logo

CRSP Net Debt

Latest reported$492.41M
CRSP Quarterly Net Debt (-$117.63M → $492.41M)
High-resolution chart · PNG

CRSP net debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Net Debt — Quarterly (USD)
Period endingNet Debt (USD)
492,411,000
364,334,000
39,726,000
113,781,000
18,320,000
-15,826,000
-74,564,000
1,875,000
-253,169,000
-472,500,000
-150,845,000
-286,179,000
-199,621,000
-104,138,000
32,136,000
-251,996,000
-254,466,001
-444,926,000
-698,001,000
-806,173,000
-1,455,442,000
-1,064,588,000
-1,107,191,000
-992,207,000
-894,845,000
-838,317,000
-891,232,000
-588,085,000
-385,805,000
-400,922,000
-456,649,000
-487,295,000
-319,737,000
-341,767,000
-239,758,000
-253,519,000
-272,264,000
-288,872,000
-315,520,000
-228,613,000
-246,849,000
-200,600,000
-117,625,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.